These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24332699)

  • 1. Delving into disability in Crohn's disease: dysregulation of molecular pathways may explain skeletal muscle loss in Crohn's disease.
    van Langenberg DR; Della Gatta P; Hill B; Zacharewicz E; Gibson PR; Russell AP
    J Crohns Colitis; 2014 Jul; 8(7):626-34. PubMed ID: 24332699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Objectively measured muscle fatigue in Crohn's disease: correlation with self-reported fatigue and associated factors for clinical application.
    van Langenberg DR; Della Gatta P; Warmington SA; Kidgell DJ; Gibson PR; Russell AP
    J Crohns Colitis; 2014 Feb; 8(2):137-46. PubMed ID: 23938210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and molecular signatures of alcohol-induced myopathy in women.
    Shenkman BS; Zinovyeva OE; Belova SP; Mirzoev TM; Vilchinskaya NA; Vikhlyantsev IM; Ulanova AD; Turtikova OV; Samkhaeva ND; Parfenov VA; Barinov AN; Nemirovskaya TL
    Am J Physiol Endocrinol Metab; 2019 May; 316(5):E967-E976. PubMed ID: 30912963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal muscle dysfunction in idiopathic pulmonary arterial hypertension.
    Batt J; Ahmed SS; Correa J; Bain A; Granton J
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):74-86. PubMed ID: 23972212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
    Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
    J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of PI3K/Akt/mTOR signaling pathway triggered by PTEN downregulation in the pathogenesis of Crohn's disease.
    Long SH; He Y; Chen MH; Cao K; Chen YJ; Chen BL; Mao R; Zhang SH; Zhu ZH; Zeng ZR; Hu PJ
    J Dig Dis; 2013 Dec; 14(12):662-9. PubMed ID: 23962154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased ceramide content and NFκB signaling may contribute to the attenuation of anabolic signaling after resistance exercise in aged males.
    Rivas DA; Morris EP; Haran PH; Pasha EP; Morais Mda S; Dolnikowski GG; Phillips EM; Fielding RA
    J Appl Physiol (1985); 2012 Dec; 113(11):1727-36. PubMed ID: 23042913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 3 days unloading on molecular regulators of muscle size in humans.
    Gustafsson T; Osterlund T; Flanagan JN; von Waldén F; Trappe TA; Linnehan RM; Tesch PA
    J Appl Physiol (1985); 2010 Sep; 109(3):721-7. PubMed ID: 20538844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrophy and hypertrophy signalling of the quadriceps and diaphragm in COPD.
    Doucet M; Dubé A; Joanisse DR; Debigaré R; Michaud A; Paré MÈ; Vaillancourt R; Fréchette E; Maltais F
    Thorax; 2010 Nov; 65(11):963-70. PubMed ID: 20965933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dynamical system for the IGF1-AKT signaling pathway in skeletal muscle adaptation.
    Villota-Narvaez Y; Garzon-Alvarado DA; Ramirez-Martinez AM
    Biosystems; 2021 Apr; 202():104355. PubMed ID: 33453318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.
    Rommel C; Bodine SC; Clarke BA; Rossman R; Nunez L; Stitt TN; Yancopoulos GD; Glass DJ
    Nat Cell Biol; 2001 Nov; 3(11):1009-13. PubMed ID: 11715022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic paraplegia-induced muscle atrophy downregulates the mTOR/S6K1 signaling pathway.
    Dreyer HC; Glynn EL; Lujan HL; Fry CS; DiCarlo SE; Rasmussen BB
    J Appl Physiol (1985); 2008 Jan; 104(1):27-33. PubMed ID: 17885021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of Akt signaling enhances femoral fracture healing by accelerating atrophic quadriceps recovery.
    Li G; Wang L; Jiang Y; Kong X; Fan Q; Ge S; Hao Y
    Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2848-2861. PubMed ID: 28778592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain Transition.
    Umeki D; Ohnuki Y; Mototani Y; Shiozawa K; Suita K; Fujita T; Nakamura Y; Saeki Y; Okumura S
    PLoS One; 2015; 10(6):e0128263. PubMed ID: 26053620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy.
    Glass DJ
    Nat Cell Biol; 2003 Feb; 5(2):87-90. PubMed ID: 12563267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep and physical activity measured by accelerometry in Crohn's disease.
    van Langenberg DR; Papandony MC; Gibson PR
    Aliment Pharmacol Ther; 2015 May; 41(10):991-1004. PubMed ID: 25783784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akt/mTOR pathway contributes to skeletal muscle anti-atrophic effect of aerobic exercise training in heart failure mice.
    Bacurau AV; Jannig PR; de Moraes WM; Cunha TF; Medeiros A; Barberi L; Coelho MA; Bacurau RF; Ugrinowitsch C; Musarò A; Brum PC
    Int J Cardiol; 2016 Jul; 214():137-47. PubMed ID: 27060274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass.
    Frost RA; Lang CH
    J Appl Physiol (1985); 2007 Jul; 103(1):378-87. PubMed ID: 17332274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of IGF-1 Signaling in Skeletal Muscle Atrophy.
    Timmer LT; Hoogaars WMH; Jaspers RT
    Adv Exp Med Biol; 2018; 1088():109-137. PubMed ID: 30390250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced nuclear translocation of serum response factor is associated with skeletal muscle atrophy in a cigarette smoke-induced mouse model of COPD.
    Ma R; Gong X; Jiang H; Lin C; Chen Y; Xu X; Zhang C; Wang J; Lu W; Zhong N
    Int J Chron Obstruct Pulmon Dis; 2017; 12():581-587. PubMed ID: 28260872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.